The Wire · Case news
Court rulings, settlements, and case developments, with links to the source records.
Roundup lawsuit: who may qualify and what happens next
On Sept. 29, 2026, attorneys for three cancer patients told a Missouri jury that Bayer's Monsanto unit failed to adequately test Roundup weedkiller before selling it. The trial is the first of its kind since a U.S. Supreme Court ruling affecting some Roundup claims, according to Reuters and Insurance Journal.
Source: insurancejournal.com
Nursing Home Abuse & Elder Abuse
On September 29, 2026, UK Prime Minister Andy Burnham set out plans for a new National Care Service, which the government says would include a state pension that rises yearly and the elimination of personal care charges for older people, according to a GOV.UK announcement.
Source: gov.uk
AFFF Firefighting Foam
According to The Cool Down, towns in New Hampshire filed lawsuits against 3M and DuPont, alleging that PFAS chemicals used in firefighting gear exposed firefighters to an increased cancer risk.
Source: news.google.com
Instant Soup Burns
A new lawsuit alleges that a Best Buy Insignia pressure cooker had a defective lid that allowed the appliance to open under pressure, causing severe burn injuries, according to AboutLawsuits.com.
Source: news.google.com
Paraquat Parkinson’s
A news report published by GreaterGood and indexed via Google News on September 30, 2026, alleges that hidden safety data shows the maker of paraquat withheld key records from the EPA. The report does not describe any new regulatory action, lawsuit filing, or court ruling.
Source: news.google.com
Ozempic / GLP-1 Lawsuits
A report from MedShadow Foundation, carried via Google News, noted an FDA warning that some GLP-1 injector pens may contain no medication. Separately, newly published research examined GLP-1 receptor agonists in connection with orofacial adverse events, maternal pregnancy outcomes, and psychiatric hospitalization in bipolar disorder.
Source: news.google.com
Medical Malpractice
A cancer patient in Ohio has filed a lawsuit against a hospital, alleging her surgeon amputated the wrong leg during a required amputation procedure, leaving her a double amputee, according to Fox News and the Daily Mail.
Source: foxnews.com
Roundup lawsuit: who may qualify and what happens next
Monsanto began a new Roundup trial in Missouri, the first since the U.S. Supreme Court’s June 25, 2026 decision in Monsanto v. Durnell, which held that FIFRA preempts state-law failure-to-warn claims that would require a cancer warning on Roundup’s label, according to Reuters, Law360, and CVN. Opening statements were heard in the case, described by trial coverage outlet CVN as a closely watched 'post-Durnell' proceeding.
Source: news.google.com
GLP-1 Vision Loss (Ozempic / Wegovy NAION)
News reports from the New York Post and other outlets describe hundreds of lawsuits against GLP-1 drug makers, with plaintiffs alleging the drugs were not adequately labeled to warn of potential vision loss. A separate report notes Wegovy may carry a higher risk of 'eye stroke' than other GLP-1 drugs, and a new systematic review examined possible links between GLP-1 receptor agonist use and age-related macular degeneration.
Source: news.google.com
Wrongful Death Lawsuit
The East Bay Regional Parks District reached a settlement with the family of a man who was tased and left in a comatose state, according to KQED. Attorneys involved did not confirm specific settlement terms and indicated a joint press release would follow.
Source: kqed.org
Bard PowerPort Catheter
The FDA logged a Class I recall for Bard Access Systems' Power-Trialysis Short-Term Straight Dialysis Catheter (REF 5605150). The agency's database describes this as a downstream recall tied to an earlier Class I recall, RES 98777.
Source: api.fda.gov
Bard PowerPort Catheter
The FDA's enforcement database lists a Class I recall for the Bard Access Systems Power-Trialysis Short-Term Straight Dialysis Catheter (REF 5605150), identified as a downstream recall tied to an earlier recall event, RES 98777.
Source: api.fda.gov